CARM
Price
$0.45
Change
-$0.10 (-18.18%)
Updated
Jun 13 closing price
Capitalization
18.87M
PMVP
Price
$1.08
Change
-$0.01 (-0.92%)
Updated
Jun 13 closing price
Capitalization
56.11M
53 days until earnings call
Interact to see
Advertisement

CARM vs PMVP

Header iconCARM vs PMVP Comparison
Open Charts CARM vs PMVPBanner chart's image
Carisma Therapeutics
Price$0.45
Change-$0.10 (-18.18%)
Volume$12.77M
Capitalization18.87M
PMV Pharmaceuticals
Price$1.08
Change-$0.01 (-0.92%)
Volume$176.84K
Capitalization56.11M
CARM vs PMVP Comparison Chart
Loading...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CARM vs. PMVP commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARM is a Hold and PMVP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (CARM: $0.45 vs. PMVP: $1.08)
Brand notoriety: CARM and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CARM: 69% vs. PMVP: 72%
Market capitalization -- CARM: $18.87M vs. PMVP: $56.11M
CARM [@Biotechnology] is valued at $18.87M. PMVP’s [@Biotechnology] market capitalization is $56.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARM’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • CARM’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, PMVP is a better buy in the long-term than CARM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARM’s TA Score shows that 5 TA indicator(s) are bullish while PMVP’s TA Score has 5 bullish TA indicator(s).

  • CARM’s TA Score: 5 bullish, 4 bearish.
  • PMVP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CARM is a better buy in the short-term than PMVP.

Price Growth

CARM (@Biotechnology) experienced а +132.90% price change this week, while PMVP (@Biotechnology) price change was +11.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

PMVP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMVP($56.1M) has a higher market cap than CARM($18.9M). CARM YTD gains are higher at: 7.832 vs. PMVP (-28.477). CARM has higher annual earnings (EBITDA): -49.68M vs. PMVP (-87.97M). PMVP has more cash in the bank: 160M vs. CARM (7.74M). PMVP has less debt than CARM: PMVP (1.11M) vs CARM (2.33M). CARM has higher revenues than PMVP: CARM (20M) vs PMVP (0).
CARMPMVPCARM / PMVP
Capitalization18.9M56.1M34%
EBITDA-49.68M-87.97M56%
Gain YTD7.832-28.477-28%
P/E RatioN/AN/A-
Revenue20M0-
Total Cash7.74M160M5%
Total Debt2.33M1.11M210%
FUNDAMENTALS RATINGS
CARM: Fundamental Ratings
CARM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CARMPMVP
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
73%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPHI1.630.04
+2.52%
China Pharma Holdings Inc
MOH298.144.66
+1.59%
Molina Healthcare
CAPL21.91-0.23
-1.04%
CrossAmerica Partners LP
PBH83.97-1.17
-1.37%
Prestige Consumer Healthcare
VERI1.40-0.07
-4.76%
Veritone

CARM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARM has been loosely correlated with EVGN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CARM jumps, then EVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARM
1D Price
Change %
CARM100%
-17.62%
EVGN - CARM
58%
Loosely correlated
-9.21%
NKTR - CARM
42%
Loosely correlated
-1.94%
INSM - CARM
41%
Loosely correlated
+1.91%
PMVP - CARM
35%
Loosely correlated
-0.92%
ABCL - CARM
31%
Poorly correlated
+1.59%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with XNCR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-0.92%
XNCR - PMVP
42%
Loosely correlated
-2.55%
COGT - PMVP
39%
Loosely correlated
-1.94%
CLLS - PMVP
39%
Loosely correlated
-2.69%
VERV - PMVP
38%
Loosely correlated
-2.53%
CCCC - PMVP
36%
Loosely correlated
+3.70%
More